Shilpa Medicare, a full-service CDMO (Contract Development and Manufacturing Organization), has launched its new Flow Chemistry Centre of Excellence (CoE) at its Bengaluru site in Dobbespet, Avarahalli Industrial Area...
Medanta, one of India’s leading super-specialty healthcare providers, has taken a major step in advancing eye care with the launch of the UNITY Vitreoretinal Cataract System (VCS) at Medanta Mediclinic, Defence Colony, New Delhi...
The third-largest pharmaceutical business in India, Cipla, has finalized its long-discussed succession plan by confirming that Achin Gupta, its Global COO (GCOO), will be promoted to the position of Managing Director (MD) and Global CEO (GCEO) on
Roche today announced that it has been awarded CE mark for its Elecsys Dengue Ag test, a high-throughput, completely automated immunoassay intended to support the diagnosis of acute dengue virus infection. This achievement represents a...
India has increased its trade protection actions by broadening an anti-dumping probe concerning the import of Ethambutol Hydrochloride, which is a major one of the six essential active pharmaceutical ingredient
The EU GMP certification has significantly enhanced the alignment of Indian pharmaceutical manufacturing facilities with global quality standards, according to Arpit Bhatia, director of Laborate Pharmaceuticals
Novartis has formally closed its acquisition of Tourmaline Bio, a strategic step to advance its leadership in cardiovascular innovation. After the closing, common stock of Tourmaline, with each share having a par value of $0.0001, has ceased...
.png "Amway to Invest $12 Million in India to Expand Stores")
US direct sales market leader Amway will pump in USD 12 million (approximately Rs 100 crore) in India in the next three to five years to augment retail reach and deepen distribution network. The decision is in line with Amway's increasing focus...
The U.S. Food and Drug Administration (FDA) has given approval to Lynkuet (elinzanetant), Bayer's dual neurokinin (NK) receptor antagonist that is not accompanied by the use of hormones
Merck & Co. and Eisai Co., Ltd. reported that their kidney cancer drug combo of Welireg and Lenvima met one main goal in a late stage trial for advanced renal cell carcinoma. The combo showed a significant improvement in progression free...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")